CA2875069 AGENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTICANCER AGENT

Settings

Stemming

Single Family Member

Include NPL

Feedback

Goto Application

Office

Canada

Application Number 2875069

Application Date 17.05.2013

Publication Number 2875069

Publication Date 05.12.2013

Grant Number

Grant Date 02.01.2018

Publication Kind C

IPC

CPC

View more classifications

View less classifications

Applicants KINKI UNIVERSITY
ASAHI KASEI PHARMA CORPORATION

Inventors KAWABATA, ATSUFUMI
SUZUKI, HIDEAKI

Priority Data 2012-125316 31.05.2012 JP

Title

(EN) AGENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTICANCER AGENT

(FR) AGENT DE PREVENTION ET/OU DE TRAITEMENT D'UNE DOULEUR NEUROPATHIQUE PERIPHERIQUE CAUSEE PAR UN MEDICAMENT ANTICANCEREUX

Abstract

(EN) A medicament effective for prophylactic and/or therapeutic treatment of a peripheral neuropathic pain such as allodynia caused by a treatment with an anticancer agent, which comprises thrombomodulin as an active ingredient.

(FR) L'invention concerne un médicament efficace dans la prévention et/ou le traitement d'une douleur neurophatique périphérique, telle que l'allodynie, causée par un traitement par médicament anticancéreux ; le médicament contenant de la thrombomoduline en tant que principe actif.

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38	Medicinal preparations containing peptides
16	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
55	Protease inhibitors

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
335	having oxygen as the only ring hetero atom, e.g. fungichromin
337	having four-membered rings, e.g. taxol

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25	Drugs for disorders of the nervous system
04	Centrally acting analgesics, e.g. opioids

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
K	PEPTIDES
14	Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435	from animals; from humans
46	from vertebrates
47	from mammals

C	CHEMISTRY; METALLURGY
12	BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N	MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15	Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09	Recombinant DNA-technology

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. CA2875069 - AGENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTICANCER AGENT